Clinical Trials Directory

Trials / Completed

CompletedNCT01992185

Photocil (Topical) for the Treatment of Vitiligo

Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Vitiligo

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Applied Biology, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of vitiligo.

Detailed description

NB-UVB phototherapy is a common treatment for patients with psoriasis, and has been reported to be safe and effective in numerous clinical trials. Clinical trials have reported achievement of Vitiligo Area Severity Index (VASI)-75 in 50-70% of patients after 4-6 weeks of NB-UVB treatment. Many drawbacks limit patients compliance, access, and acceptance of traditional NB-UVB phototherapy. The strict treatment regimen (2-3 sessions per week for an average of 12 weeks or more) performed at a specialized phototherapy clinic combined with high cost and low or no reimbursement make compliance and access a major drawback. In order to address the drawbacks of phototherapy, we developed a novel topical cream - Photocil - that selectively delivers NB-UVB therapy when exposed to sunlight. When used with natural sunlight, Photocil provides a convenient alternative to traditional clinic based phototherapy; thus, has the potential to dramatically increase patient compliance and treatment outcome.

Conditions

Interventions

TypeNameDescription
DRUGPhotocil for VitiligoPhotocil for Vitiligo
OTHERPlacebo - Sunscreen (SPF 2)Placebo - Sunscreen (SPF 2)

Timeline

Start date
2013-08-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-11-25
Last updated
2016-03-10
Results posted
2016-03-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01992185. Inclusion in this directory is not an endorsement.